In vivo visualization of MET tumor expression and anticalin biodistribution with the MET-specific anticalin 89Zr-PRS-110 PET tracer.

MLA

Terwisscha van Scheltinga, Anton G. T., et al. “In Vivo Visualization of MET Tumor Expression and Anticalin Biodistribution with the MET-Specific Anticalin 89Zr-PRS-110 PET Tracer.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 55, no. 4, Apr. 2014, pp. 665–71. EBSCOhost, https://doi.org/10.2967/jnumed.113.124941.

APA

Terwisscha van Scheltinga, A. G. T., Lub-de Hooge, M. N., Hinner, M. J., Verheijen, R. B., Allersdorfer, A., Hülsmeyer, M., Nagengast, W. B., Schröder, C. P., Kosterink, J. G. W., de Vries, E. G. E., Audoly, L., & Olwill, S. A. (2014). In vivo visualization of MET tumor expression and anticalin biodistribution with the MET-specific anticalin 89Zr-PRS-110 PET tracer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 55(4), 665–671. https://doi.org/10.2967/jnumed.113.124941

Chicago

Terwisscha van Scheltinga, Anton G T, Marjolijn N Lub-de Hooge, Marlon J Hinner, Remy B Verheijen, Andrea Allersdorfer, Martin Hülsmeyer, Wouter B Nagengast, et al. 2014. “In Vivo Visualization of MET Tumor Expression and Anticalin Biodistribution with the MET-Specific Anticalin 89Zr-PRS-110 PET Tracer.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 55 (4): 665–71. doi:10.2967/jnumed.113.124941.